925
Participants
Start Date
July 30, 2019
Primary Completion Date
May 3, 2021
Study Completion Date
January 20, 2023
MEDI8897
Anti-RSV monoclonal antibody with an extended half-life
Palivizumab
Approved anti-RSV monoclonal antibody
Research Site, Riga
Research Site, Budapest
Research Site, Brussels
Research Site, Sofia
Research Site, Caen
Research Site, Sofia
Research Site, Soweto
Research Site, Johannesburg
Research Site, Johannesburg
Research Site, Montana
Research Site, Miskolc
Research Site, Plovdiv
Research Site, Plovdiv
Research Site, Debrecen
Research Site, Pazardzhik
Research Site, Veliko Tarnovo
Research Site, Pleven
Research Site, Kecskemét
Research Site, Baja
Research Site, Rousse
Research Site, Cape Town
Research Site, Cape Town
Research Site, Christchurch
Research Site, Graz
Research Site, Sliven
Research Site, Ghent
Research Site, Mineola
Research Site, Marseille
Research Site, Syracuse
Research Site, Tallinn
Research Site, Prague
Research Site, Ansan-si
Research Site, Suwon
Research Site, Washington D.C.
Research Site, Vinnytsia
Research Site, Charlottesville
Research Site, Lleida
Research Site, Morgantown
Research Site, Durham
Research Site, Greenville
Research Site, Madrid
Research Site, Pozuelo de Alarcón
Research Site, Boadilla del Monte
Research Site, Leganés
Research Site, Málaga
Research Site, Greenville
Research Site, Brest
Research Site, Atlanta
Research Site, Bordeaux
Research Site, Tampere
Research Site, Izmir
Research Site, Verona
Research Site, Grenoble
Research Site, Jackson
Research Site, Sumy
Research Site, Louisville
Research Site, Kocaeli
Research Site, Tarragona
Research Site, Columbus
Research Site, Cincinnati
Research Site, Indianapolis
Research Site, South Bend
Research Site, Kaunas
Research Site, Dnipro
Research Site, Kaunas
Research Site, West Des Moines
Research Site, Tartu
Research Site, Pisa
Research Site, Chernivtsі
Research Site, Chicago
Research Site, Kharkiv Region
Research Site, Cuernavaca
Research Site, Pau
Research Site, Odesa
Research Site, Columbia
Research Site, Frankenthal
Research Site, Mannheim
Research Site, Bron
Research Site, Ivano-Frankivsk
Research Site, Corpus Christi
Research Site, Aurora
Research Site, Amiens
Research Site, Colorado Springs
Research Site, Layton
Research Site, St. George
Research Site, Los Angeles
Research Site, Paramount
Research Site, Long Beach
Research Site, West Covina
Research Site, National City
Research Site, Anaheim
Research Site, Créteil
Research Site, Seattle
Research Site, Yaroslavl
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Kazan'
Research Site, Perm
Research Site, Novosibirsk
Research Site, Edmonton
Research Site, Vancouver
Research Site, Leipzig
Research Site, Fukui-shi
Research Site, Fukuoka
Research Site, Kitakyusyu-shi
Research Site, Maebashi
Research Site, Saitama Shi
Research Site, Setagaya-ku
Research Site, Jēkabpils
Research Site, Riga
Research Site, México
Research Site, Bydgoszcz
Research Site, Gdansk
Research Site, Krakow
Research Site, Krakow
Research Site, Wroclaw
Research Site, Pretoria
Research Site, Pretoria
Research Site, Seoul
Research Site, Alicante
Research Site, Elche
Research Site, Sant Cugat del Vallès
Research Site, Stockholm
Research Site, Adana
Research Site, Leicester
Research Site, London
Research Site, Nottingham
Lead Sponsor
AstraZeneca
INDUSTRY